Page 22 - IJB-2-2
P. 22

3D bioprinting technology for regenerative medicine applications

            (PEGDMA)  was successfully used to  print cartilage   short peptides based hydrogels was demonstrated by
            construct containing human articular chondrocytes [95] .   maintaining the organotypic culture of intestinal epi-
            In this study, PEG has been utilized as 3D biopaper to   thelial cells (Caco2) and 3D culture of stem cells. It
            make constructs that repair osteochondral plugs [95] .   was  shown that embryonic  stem  cells encapsulated
               (3) Poly(L-lactic acid) (PLA)                   within these  ultrashort  peptide hydrogels can retain
               PLA is an aliphatic  polymer with glass transition   their pluripotency, using Tra-I-60, Tra-I-81, Oct4 and
            temperature  of 60°C and an  excellent mechanical   Nanog  as pluripotency  markers [72] . Furthermore, hu-
            strength. It is a biodegradable, biocompatible and se-  man  mesenchymal stem cells encapsulated  in these
            micrystalline polymer  used  for various  tissue engi-  peptide based hydrogels differentiated into adipogenic
            neering applications. As a bioink, PLA is less viscous   lineage under defined culture conditions. It was pro-
            in nature and can be easily ejected through the needle.   posed that these peptide hydrogels can offer a suitable
            After printing, PLA exhibits faster evaporation and can   nanotopography and 3D microenvironment to support
            provide structural integrity to the construct. Recently,   organotypic culture  of  primary cells (gastrointestinal
            an acrylonitrile butadiene styrene-PLA blend was used   and skin cells) as well as 3D culture of stem cells [72,98] .
            as a bioink to produce  a  cartilage graft [96] . Nucleus   Bioinks made from these  ultrashort  peptides exhibit
            pulposus and primary articular chondrocytes cultured   interesting properties that could be useful for the de-
            on this scaffold maintained their native phenotypes   velopment of 3D organotypic cultures for drug scree-
            over three weeks [96] .                            ning and  biological constructs for tissue  engineering
               (4) Poly(ε-caprolactone) (PCL)                  applications in the future [100] .
               PCL is a synthetic polyester which is semicrystal-
            line, biocompatible and biodegradable. It is an easily   6. Applications of Bioprinting
            processable bioink due to its excellent properties such   Bioprinting makes use of novel bioinks and 3D print-
            as low melting point,  thermoplastic behavior, hydro-  ing techniques to fabricate closely resembling organs/
            lytic degradation and  excellent mechanical proper-  tissues for regenerative medicine  applications. Bio-
            ties [97] . Initially, PCL being a viscous solution had dif-  printing techniques make it possible to print cells in
            ficulties in printing  because of the requirement of   the constructs in specific locations which is important
            large diameter nozzle and high pressure. To overcome   for  mimicking native tissue  architecture [19] .  As dis-
            this problem, an electrohydrodynamic  jet technique   cussed  in  section 2, there are  several  structural and
            was used to  print PCL  bioinks. Applying electrohy-  functional  features  that  are considered ideal  for  de-
            drodynamic  forces  created a temperature gradient in   veloping 3D constructs. Among the structural features,
            the ink and high resolution (10 μm) 3D constructs were   vasculature is one of the important factors that deter-
            formed [97] . However, PCL cannot be used as cell-laden   mine the success of bioprinted constructs by improv-
            bioink  due to its  high melting point (60°C). Instead   ing cell viability [48] . The vasculature of 3D constructs
            PCL can be used to provide supporting structure in 3D   is essential to improve nutrient delivery, tissue ingro-
            constructs and also to reinforce stability to the fabri-  wth, and regeneration [53] . Cells in tissues are mostly
            cated scaffolds [9,97] . Though synthetic polymers offer   found within 100-200 μm away from adjacent blood
            many advantages in bioprinting, further developments   vessels. Cells that are present within this limit of 100-
            are required to improve the biocompatibility and de-  200 μm receive nutrition and oxygen through diffusion
            gradation behavior of this class of polymers.      from the nearby capillaries. Hence bioprinted 3D con-

            5.3 Ultrashort Peptides                            structs  need to  be  prevascularized to  overcome this
                                                               diffusion limit and also to mimic the native tissue [69] .
            Hauser and co-workers have recently reported  that   Several bioprinting approaches  have  been shown to
            distinct peptides selected from the earlier discovered   stimulate vascularization of scaffolds for tissue engi-
            class of  self-assembling ultrashort peptides can  be   neering applications [19,41,53]   . For example, a 3D micro-
            used as  bioinks for bioprinting applications [98–100] .   vascular construct was  printed  using human micro-
            These ultrashort peptides have an innate tendency to   vascular endothelial cells and fibrin as bioinks [53] . In
            self-assemble into hydrogels with a nanofibrous topo-  the case of cell viability, numerous studies have dem-
            graphy that closely resemble  collagen  and thus mi-  onstrated that there was no difference in cell viability
            micking the  native architecture  of  tissue ECM [72,98] .   between non-printed and printed cells [48,101] . Cell via-
            As an example, the  biocompatibility of these  ultra-  bility and vasculature are some of the important para-

            18                          International Journal of Bioprinting (2016)–Volume 2, Issue 2
   17   18   19   20   21   22   23   24   25   26   27